Literature DB >> 12690429

Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia.

Xing Cheng1, Susan W S Leung, Lawrence S Lo, Catherine C Y Pang.   

Abstract

The late phase of severe septic shock is associated with reduced cardiac output (CO) and activation of the inducible isoform of nitric oxide synthase (NOS). This study examined the effects of 1400 W (N-3-aminomethyl-benzyl-acetamidine), a new selective inhibitor of inducible NOS (iNOS), relative to those of N(G)-nitro-L-arginine (L-NNA, non-selective inhibitor of NOS) and the vehicle, on mean arterial pressure (MAP), CO, total peripheral resistance (TPR) and tissue blood flow (BF) in thiobutabarbital-anesthetized rats with lipopolysaccharide (LPS, 10 mg/kg, i.v.) induced endotoxemia. At 2.5 as well as 4 h after injection of LPS, MAP, CO, and BF of the stomach, skeletal muscle and skin were decreased, but TPR was increased, BF to the heart and kidneys were also decreased at 4 h after injection of LPS. Treatment of endotoxemic rats with 1400 W (3 mg/kg followed by 3 mg/kg/h, i.v.) at 2.5 h after endotoxin challenge prevented the late phase fall in MAP without exacerbating the decreases in CO and tissue BF. In contrast, treatment with L-NNA (8 mg/kg followed by 3 mg/kg/h, i.v.) at 2.5 h did not prevent the decline in MAP in the LPS-treated rats. Furthermore, CO drastically decreased, TPR markedly increased, and BF to the heart, brain, intestine and skeletal muscle were decreased at 4 h relative to the readings in saline- or 1400 W-treated endotoxemic rats. Therefore, selective inhibition of iNOS by 1400 W restores MAP without compromising CO, but non-selective inhibition of NOS is detrimental at the late stage of septic shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690429     DOI: 10.1007/s00210-002-0684-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  43 in total

1.  Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist.

Authors:  C Mitaka; Y Hirata; K Yokoyama; T Nagura; Y Tsunoda; K Amaha
Journal:  Crit Care Med       Date:  1999-01       Impact factor: 7.598

2.  Helicobacter pylori lipopolysaccharide-provoked injury to rat gastroduodenal microvasculature involves inducible nitric oxide synthase.

Authors:  J Kiss; D Lamarque; A P Moran; J Pozsár; E Morschl ; F László; B J Whittle
Journal:  Eur J Pharmacol       Date:  2001-05-25       Impact factor: 4.432

3.  Effects of selective nitric oxide synthase inhibition in hyperdynamic endotoxemia in dogs.

Authors:  A Wolfárd; J Kaszaki; C Szabó; Z Balogh; S Nagy; M Boros
Journal:  Eur Surg Res       Date:  1999       Impact factor: 1.745

Review 4.  Nitric oxide synthases: catalytic function and progress towards selective inhibition.

Authors:  B Mayer; P Andrew
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1998-07       Impact factor: 3.000

5.  Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA.

Authors:  S Liu; I M Adcock; R W Old; P J Barnes; T W Evans
Journal:  Biochem Biophys Res Commun       Date:  1993-11-15       Impact factor: 3.575

6.  Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin.

Authors:  G M Wray; C G Millar; C J Hinds; C Thiemermann
Journal:  Shock       Date:  1998-05       Impact factor: 3.454

7.  Effect of vasopressin antagonist and saralasin on regional blood flow following hemorrhage.

Authors:  C C Pang
Journal:  Am J Physiol       Date:  1983-11

8.  Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: investigations using the selective inhibitors, 1400W and celecoxib.

Authors:  L C Hamilton; T D Warner
Journal:  Br J Pharmacol       Date:  1998-09       Impact factor: 8.739

9.  The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase.

Authors:  C Thiemermann; H Ruetten; C C Wu; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

10.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

View more
  4 in total

1.  Epidural analgesia in sepsis: too early to judge a new concept.

Authors:  Andreas W Sielenkämper; Hugo Van Aken
Journal:  Intensive Care Med       Date:  2004-09-24       Impact factor: 17.440

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response.

Authors:  Sheila M Gardiner; Julie E March; Philip A Kemp; Terence Bennett
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

4.  Involvement of the sympathetic nervous system in the reversal of critical haemorrhagic hypotension by endogenous central histamine in rats.

Authors:  Jerzy Jochem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-28       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.